DDEL-01. ENGINEERING MRNA THERAPIES FOR BRAIN TUMORS
Saigopalakrishna S. Yerneni(Carnegie Mellon University), Kathryn A. Whitehead(Carnegie Mellon University), Linda M. McAllister‐Lucas(University of Michigan), Juliana H. Azambuja(University of Pittsburgh), Brendan R. Gallagher(Carnegie Mellon University), Peter C. Lucas(University of Pittsburgh), Norbert Pardi(University of Pennsylvania), Drew Weissman(California University of Pennsylvania), Namit Chaudhary(Scripps Research Institute), Yongxin Zhao(IIT@MIT), Daria Strelkova-Petersen(Carnegie Mellon University), Julie Shin Kim(Carnegie Mellon University)
Cited by 0
Related Papers
mRNA vaccines — a new era in vaccinology
|Nature Reviews Drug Discovery|2018|4.4k
Knocking down barriers: advances in siRNA delivery
|Nature Reviews Drug Discovery|2009|3.1k
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
|Nature Reviews Drug Discovery|2021|1.5k
CAR T Cells Produced in vivo to Treat Cardiac Injury
|HAL (Le Centre pour la Communication Scientifique Directe)|2023|940